Search
for
Sort by
Research 31–60 of 1000+
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- Comment on “A Cross-sectional Observational Study to Correlate the Trichoscopic Findings of Female Pattern Hair Loss with the Disease Severity and Underlying Histopathological Changes”
- Response to the article, “Evaluation of standardized scalp photography on patient perception of hair loss severity, anxiety, and treatment,” by Pathoulas et al
- 75478 Symptoms, Emotional and Functional Impacts by Hair Loss Severity in Alopecia Areata
- Injection Therapies for Hair Loss in a Cosmetic Practice
- Vitmain D level in female pattern hair loss with normal androgen level
- A practical guide to the standardization of hair loss photography for clinicians
- Identification of Stress-Related Hair Loss and Prevention Through the Application of a KNN Model Based on Machine Learning
- Female pattern hair loss: current treatment concepts.
- A new classification of early female pattern hair loss
- Alopecia and grey hair are associated with COVID‐19 Severity
- Quality of life and economic burden assessment in Korean patients with male and female pattern hair loss
- Determinants of Occipital Involvement in Males and Females with Pattern Hair Loss: A Retrospective Study
- Advancing Hair Loss Assessment in Alopecia Areata: The Mathematical Case for Centralised, Standardised Imaging
- 701 Rethinking alopecia scores: Correlating measures of hair loss with established photographic scoring systems
- The Predictive Value of Midscalp Hair Density and Terminal Hair Percentage in the Severity Evaluation of FPHL Assessed by Trichoscan in a Sample of Chinese Population
- Contact sensitization to hair care allergens in scalp seborrheic dermatitis: associations with disease severity and microbiota profiles
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- 62202 Network meta-analysis (NMA) of FDA-approved JAK inhibitors for alopecia areata (AA) with at least 50% hair loss per SALT score
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia
- Evaluation of Automated Measurement of Hair Density Using Deep Neural Networks
- More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
- Prevalence and severity of cutaneous manifestations in patients of CRF on hemodialysis in relation to duration of replacement therapy
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Comparison of Alopecia severity and blood level of testosterone in men suffering schizophrenia with control group
- ASSESSMENT OF THE SEVERETY OF ANDROGENETIC ALOPECIA USING TRICHOSCOPIC FEATURES AND THEIR CORRELATION WITH HISTOMORPHOLOGICAL FINDINGS
- The Protective and Regenerative Potential of Lactoferrin in Hair and Skin Health
- Assessment of miR-19b-3p, miR-182-5p, and miR-155-5p expression and its relationship with alopecia areata severity